Inflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist

Similar documents
POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Autoantibodies in the Idiopathic Inflammatory Myopathies

L. Nandini Moorthy, MD MS 2012

Rheumatology E-learning. University of Szeged Department of Rheumatology and Immunology

What your autoantibodies tell us about your disease. Mark Gourley, MD

IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS. Franclo Henning Division of Neurology Tygerberg Hospital

Autoantibodies andprognosis. Jiří Vencovský Institute of Rheumatology, Prague, Czech Republic

Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

HUNGARIAN MYOSITIS COHORT

Myositis and Your Lungs

Myositis 101. Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic, Rochester, MN

Idiopathic inflammatory myopathies excluding inclusion body myositis

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Autoantibodies in Idiopathic Inflammatory Myopathies. Vidya Limaye Rheumatology Department Royal Adelaide Hospital

What will we discuss today?

SCLERODERMA SPECTRUM DISEASE

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

An autoimmune perspective on neuromuscular diseases

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

PedsCases Podcast Scripts

Significance of antibody testing in idiopathic inflammatory myopathies

Diseases of Muscle and Neuromuscular Junction

MYOSITIS. A physician s guide to the

SCLERODERMA OVERLAP SYNDROME: A CASE REPORT Diwakar K. Singh 1, Nataraju H. V 2

Clinical Laboratory. [None

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Pulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Test Name Results Units Bio. Ref. Interval

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Test Name Results Units Bio. Ref. Interval

Evolving Uses of IVIG in myositis

Systemic autoimmune diseases

Case Report Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies

LUPUS. and Associated Conditions LUPUSUK 2018

JUVENILE DERMATOMYOSITIS

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed

DR.JANANI RAVI DR.GNANABALAN S UNIT DR.MEHTA CHILDREN HOSPITAL

A48-year-old Hispanic woman

Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Edward Dwyer, M.D. Division of Rheumatology

Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Limited vs. Diffuse Scleroderma.

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

A CRP B FBC C LFT D blood culture E uric acid

The idiopathic inflammatory myopathies

Objectives. Non-Traumatic Muscle Pathologies. Abnormal Muscle Signal Intensity. Inflammatory Myositis. Polymyostis / Dermatomyositis.

Discovery, Understanding, and Progress in Myositis

Acute Emergencies in Rheumatology

APPROACH TO PATIENTS WITH POLYARTHRALGIA

Clinical features of seven Japanese patients with anti-pl- antibody frequent positivity for anti-cyclic citrullinated peptide antibody

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies

DocSpot what patients want to know

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

LUPUS. and Associated Conditions LUPUSUK 2015

Myopathy with anti-jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres

STUDIES ON INTERLEUKIN-1 IN IDIOPATHIC INFLAMMATORY MYOPATHIES

Immune tolerance, autoimmune diseases

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Overview of Diagnostic Autoantibodies in Inflammatory Myopathy

Arthritis Superspeciality Center, Hubli, Karnataka and 2 Department of Rheumatology, SDM Medical College, Dharwad, Karnataka, India.

What are Autoantibodies and how do they work in Myositis?

Disclosures. Outline. Classification of scleroderma. Forms of SSc Like Syndromes. Systemic Sclerosis (Scleroderma)

TMA San Diego September 7, 2017

When to Suspect Autoimmune Disease. Michael Cho, MD, Group Health

*Pari Basharat ABSTRACT OVERVIEW OF IDIOPATHIC INFLAMMATORY MYOPATHIES

REFERRAL GUIDELINES: RHEUMATOLOGY

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D.

Rheumatology 101 A Pediatrician s Guide

Systemic forms of stiffness

Idiopathic inflammatory myopathies

High Impact Rheumatology

SLE-key Case Studies

SCLERODERMA. Scleroderma update. No disclosures or conflicts. Leslie Kahl, M.D. April 10, 2015

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand

myopathy and interstitial lung dise

Myositis and Autoimmune ILD

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

MYOSITIS 101. Your guide to understanding myositis

Systemic Autoimmunity

Myosites du sujet âgé

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis

Citation Clinical rheumatology (2011), 30(3)

Acquired Generalized Lipodystrophy. K30 Case Presentation Alice Chang Hoftman, M.D. Pediatric Rheumatology November 18, 2008

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Rituximab Therapy for Myopathy Associated With Anti Signal Recognition Particle Antibodies: A Case Series

SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

ACR 2017 SAN DIEGO HIGHLIGHTS - INFLAMMATORY MYOPATHIES. Nikolaos Marketos Rheumatologist Volos,

Rheumatology Potpourri. Dr. Philip A. Baer Seacourses Asia CME December 2017

SCLEROMYXEDEMA WITH SYSTEMIC INVOLVEMENT MIMICS RHEUMATIC DISEASES

Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania b. Dr. Ion Stoia Clinical Center for Rheumatic Diseases, Bucharest, Romania c

Transcription:

Inflammatory Myopathies 4 th year MBBS Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist

Case A 64 woman presents with erythematous itchy rash over back of hands & forehead. For 1 month she felt tired Tests: ESR 42, ALT & AST. GGT & ALP normal Prescribed steroid cream Over next few weeks: can t comb hair or rise from chair Rash now: forehead, eyes, anterior chest & upper back

Nails: periungal erythema Power: reduced proximal muscle strength, cannot stand from chair Cannot raise head from supine position Facial muscles normal strength Bloods: CK 8000, ANA strongly positive

Muscle biopsy: inflammatory infiltrate with myofiber necrosis & regeneration CT - CAP: mass in L ovary

Diagnosis??

Objectives Inflammatory myopathies Epidemiology Associations Clinical features Diagnosis & investigations Pathology Radiology Overlap syndromes Treatment Sjogren s syndrome

Idiopathic inflammatory myopathies (IIM) Polymyositis Dermatomyositis Juvenile dermatomyositis Inclusion body myositis (IBM)

Epidemiology Rare diseases Annual incidence of PM/DM range from 1 to 9 cases/million/year Prevalence is 2 10 per 100 000 PM is more frequent than DM Overlap syndromes with other autoimmune rheumatic diseases occur in 15 20% 4X more common in blacks than in Caucasians. F:M ratio 2:1 Can occur at any age PM 50-60 years DM :2 peaks 5 to 15 years & 45 to 65 years. IBM >50

HLA asscociation DM: HLA-DRB1 0301, DQB1 0201 JDM associated with HLA-DQA1*0501

Associations of IIM Inflammatory myopathies can occur in association with: 1. Other autoimmune connective tissue diseases such as scleroderma, SLE, RA, SS, PAN. 2. Malignancies Incidence of malignancy is higher in DM than in PM The most common tumors: Ovary Breast Melanoma Colon Treatment of Ca results in improvement of myositis

Clinical features of IIM Constitutional Muscle Skin Joint Lung Heart GI tract

Constitutional Fatigue Fever Weight loss

Skin Gottron's papules 'V'-sign Shawl'-sign Rash on the malar areas The heliotrope rash Periungual telangiectasia Nailfold capillaries changes 'mechanic's hands'

DM vs lupus Dermatomyositis Lupus

Cuticular overgrowth with periungual erythema and capillary dilatation

V sign

Shawl sign

Involvement of the nasolabial area and forehead distinguishes DM from SLE

DM vs lupus DM Lupus

holster sign lateral surface of the thighs and hips

Holster sign erythema & Gottron erythema.

Calcinosis Soft tissue calcification, which can be disabling, occurs most commonly in chronic, childhood-onset DM

Muscle Weakness: Insidious onset over 3-6 months Symmetrical Affects the large proximal muscles around the shoulders, hips, thighs, trunk, and neck. Difficulty standing from a chair, getting out of a car, climbing stairs, raising the head off the pillow or combing hair. No pain There may be impairment of chewing or dysphagia. Weakness of neck flexors Early morning stiffness

Joints Arthralgia Arthritis Rheumatoid-like Generally mild

Deforming arthropathy of polymyositis. Rheumatoid-like deformities of the hand in a patient with anti-jo-1 autoantibody. Radiograph hand, showing numerous subluxations but minimal bony erosive changes.

Lung Respiratory muscle weakness Interstitial lung disease

Heart Arrhythmias Myocarditis Pericardial effusions

GI tract Swallowing problems (upper dysphagia) If severe, aspiration of oral contents leads to chemical pneumonitis

Diagnosis

Diagnosis Muscle enzymes EMG Muscle biopsy Autoantibodies: JO-1, Mi-2, SRP MRI

Muscle enzymes CK, AST, ALT, LDH, aldolase There is a correlation between CK level and disease activity There is correlation between anti-jo-1 titre and disease activity ESR & CRP do not correlate with disease activity or response to treatment

Causes of raised CK 1. Strenuous exercise 2. Muscle trauma (a) Injury (b) EMG (c) Surgery 3. Diseases affecting muscle (a) Myositis (b) Metabolic (c) Dystrophies (d) Myocardial infarction (e) Rhabdomyolysis 4. Drugs colchicine, steroids, statins 5. Endocrine and metabolic abnormalities (a) Hypothyroidism (b) Hypokalaemia 6. Normal (a) Ethnic group (b) Increased muscle mass (c) Technical artefact

Autoantibodies Myositis-specific antibodies : Antisynthetase Jo-1: Histidyl-tRNA synthetase SRP: Signal recognition particle Mi-2: Nucleosome remodelling complex

Anti-synthetase syndrome 25% of PM and DM patients have antibodies to an aminoacyl-trna synthetase (JO-1) Clinical features: PM/DM ILD Arthritis Raynaud's phenomenon Fever mechanic's hands.

Anti-SRP Polymyositis cardiac involvement resistance to treatment.

Anti-Mi-2 DM with V sign or shawl sign. Good prognosis.

Pathology

PM: Cell-mediated cellular immune attack on muscle fibres is a prominent pathogenetic process in PM. CD8+ T-cells are abundant in the endomysial areas DM: humoral There is intense B-cell and CD4+ T-cell infiltrate in the perivascular area, suggesting a local humoral response

In PM, inflammatory infiltrates more often predominate in the endomysial area around the muscle fibres

Polymyositis The arrow indicates an area of degeneration and necrosis of myofibers in association with interstitial lymphocytic and histiocytic cellular infiltration

Polymyositis lymphocytic invasion of non-necrotic myofiber

endomysial distribution inflammatory cellular infiltrates CD8+ T cells and macrophages

In DM, infiltration predominates in the perimysial area (around the fascicles) and around small blood vessels

perimysial largely made up of CD4+ T cells, macrophages, and dendritic cells

Perifascicular atrophy

dermatomyositis atrophic, small fibers in the periphery of the fascicles (perifascicular atrophy) and the increase in fibrous tissue separating bundles of myofibers

Inclusion body myositis Begins after age 50 It is 2-3-fold more common in males. onset is insidious Distal weakness is common Weakness of quadriceps & arm flexors Light microscopy: vacuoles rimmed by basophilic material, and small, eosinophilic cytoplasmic, and nuclear inclusions Diagnosis is confirmed by electron microscopy or trichrome stain Patients do not respond to treatment

IBM Red-rimmed vacuoles (trichrome stain)

Radiology

MRI (STIR technique): Inflammation shows up as bright areas

Overlap Syndromes Association of inflammatory myopathies with connective tissue diseases Eg patients with DM who also have manifestations of systemic sclerosis such as sclerotic thickening of the dermis, contractures, esophageal hypomotility, microangiopathy, and calcium deposits Patients with the overlap of DM and systemic sclerosis may have anti-pm/scl antibody

Treatment Corticosteroids Indications for immunosuppressive agents: (i) failure to respond to high-dose steroids (ii) persistent disease activity after prolonged therapy despite initial improvement (iii) inability to taper the steroids without recurrence (iv) severe steroid side-effects. MTX and azathioprine are the immunosuppressives used most in myositis. Duration of therapy is 18-24 months

Cancer screening All patients >50 years of age should have: CXR Chest/abdomen/pelvis CT scans Mammography and gynaecological examination (F) Testicular examination in males (M) Faecal occult blood Gastroscopy/colonoscopy

Sjögren syndrome

Inflammatory autoimmune disease affecting primarily the exocrine glands. Lymphocytic infiltrates replace functional epithelium, leading to decreased exocrine secretions. Mucosal dryness is manifested as xerophthalmia (keratoconjunctivitis sicca) and xerostomia There is salivary gland enlargement.

Characteristic autoantibodies (anti-ro/ss- A and anti-la/ss-b) There is non-erosive polyarthritis & Raynaud s phenomenon Extra-glandular manifestations: vasculitis peripheral neuropathy glomerulonephritis

There is increased risk for lymphoma. Associated with other autoimmune diseases such as RA, SLE, SSc & PM

Treatment Stimulation of salivary flow by sugar-free flavored lozenges dry food, smoking, and drugs with anticholinergic side effects, which further decrease salivary flow, should be avoided Adequate oral hygiene after meals to prevent dental disease Pilocarpine to increase salivary secretion Artificial tears Hydroxychloroquine for joint pain

Questions?